BioCentury
ARTICLE | Management Tracks

Forbion welcomes McDonald from Novo, promotes two partners

Plus: Management changes at Airna, Myriad Genetics and Oncolytics

June 6, 2026 12:29 AM UTC

Among three personnel announcements this week by Forbion was the arrival of John McDonald as an operating partner with responsibility for business development and M&A. McDonald had most recently been a corporate VP for business development and M&A at Novo Nordisk A/S (CSE:NOVO B; NYSE:NVO); he previously held roles at Biogen Inc. (NASDAQ:BIIB) and MPM Capital...